Literature DB >> 17322996

Clinical significance of the duodenal papilla in patients with separate orifices for the bile and pancreatic ducts.

Kensuke Kubota1, Toshio Fujisawa, Yasunobu Abe, Masahiko Inamori, Hiroyuki Kirikoshi, Satoru Saito, Atushi Nakajima.   

Abstract

BACKGROUND: There have been few reports of separate orifices (SPO) for the bile and pancreatic ducts. The aim of this study was to elucidate the clinical significance of SPO.
METHODS: Clinical data of patients with SPO (n = 21) were compared with those of 324 patients without SPO. The duodenal papillae in the patients with SPO were classified endoscopically into three types. Furthermore, we compared three subgroups (n = 221) among 345 patients (group A, 10 patients with bile duct stones with SPO; group B, 66 patients with bile duct stones without SPO; and group C, 145 patients without bile duct dysfunction) to evaluate the bile stasis of SPO. Various factors were retrospectively analyzed to identify any relationship in patients with SPO.
RESULTS: Univariate analysis revealed that the diameter of the common bile duct, cholangiographic angulation, and the presence of common bile duct stones (CBDS) were significantly associated with the presence of SPO. Multivariate analysis of the different risk factors for SPO in all patients revealed that the presence of CBDS (relative risk, 3.000; 95% confidence interval, 1.083-8.313; P = 0.0346) and cholangiographic angulation (relative risk, 1.041; 95% confidence interval, 1.010-1.072; P = 0.0085) were independent risk factors. Moreover, univariate analysis among the three subgroups revealed that age, the presence of periampullary diverticula, the diameter of the common bile duct, and the length of the short narrow distal segment were significantly associated with the presence of SPO.
CONCLUSIONS: CBDS and cholangiographic angulation are independent risk factors for SPO. This result suggests that SPO may be associated with an elevated risk of CBDS owing to bile stasis.

Entities:  

Mesh:

Year:  2007        PMID: 17322996     DOI: 10.1007/s00535-006-1973-0

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  9 in total

1.  An anatomical-radiological study on the pancreatic duct pattern in man.

Authors:  W DAWSON; J LANGMAN
Journal:  Anat Rec       Date:  1961-01

2.  Coexistent carcinoma in congenital dilatation of the bile duct and anomalous arrangement of the pancreatico-bile duct. Carcinogenesis of coexistent gall bladder carcinoma.

Authors:  Y Sameshima; M Uchimura; Y Muto; J Maeda; H Tsuchiyama
Journal:  Cancer       Date:  1987-10-15       Impact factor: 6.860

3.  Endoscopic biliary drainage for severe acute cholangitis.

Authors:  E C Lai; F P Mok; E S Tan; C M Lo; S T Fan; K T You; J Wong
Journal:  N Engl J Med       Date:  1992-06-11       Impact factor: 91.245

Review 4.  Diagnostic criteria for chronic pancreatitis by the Japan Pancreas Society.

Authors:  T Homma; H Harada; M Koizumi
Journal:  Pancreas       Date:  1997-07       Impact factor: 3.327

5.  Association between cholangiographic angulation of the common bile duct and choledocholithiasis.

Authors:  B L Warren
Journal:  S Afr J Surg       Date:  1987-03       Impact factor: 0.375

Review 6.  Pathogenesis and treatment of gallstones.

Authors:  D E Johnston; M M Kaplan
Journal:  N Engl J Med       Date:  1993-02-11       Impact factor: 91.245

7.  The choledocho-pancreatico-ductal junction in infantile obstructive jaundice diseases.

Authors:  K Suda; T Miyano; K Hashimoto
Journal:  Acta Pathol Jpn       Date:  1980-03

8.  An angulated common bile duct predisposes to recurrent symptomatic bile duct stones after endoscopic stone extraction.

Authors:  D Keizman; M I Shalom; F M Konikoff
Journal:  Surg Endosc       Date:  2006-07-20       Impact factor: 4.584

9.  Relationships between pancreaticobiliary ductal anatomy and pancreatic ductal and parenchymal histology.

Authors:  E P DiMagno; R G Shorter; W F Taylor; V L Go
Journal:  Cancer       Date:  1982-01-15       Impact factor: 6.860

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.